Clinical Trial Automation Introducing Workflow Efficiency
The administrative burden associated with managing a modern clinical trial is immense. From the initial regulatory filings to the final analysis of thousands of...
Smarter Site Selection Improving Clinical Trial Performance
Selecting the right investigative sites is perhaps the most consequential decision in the entire clinical trial lifecycle. A study can have a groundbreaking molecule...
New Trial Technologies Accelerating Clinical Evidence
The traditional methods of gathering clinical evidence have often been criticized for being slow and burdensome and disconnected from the daily lives of patients....
AI Transforming Clinical Trial Design and Execution
The pharmaceutical industry stands at the threshold of a new era where clinical trial artificial intelligence integration is no longer a futuristic concept but...
Predictive Analytics Reshaping Clinical Trial Planning
The strategic planning of a clinical study has historically been a process reliant on expert intuition and historical precedents. While these elements remain valuable...
Real World Evidence Strengthening Clinical Trial Design
The reliance on randomized controlled trials as the sole source of evidence for drug approvals is gradually evolving to include insights from everyday clinical...
U.S. FDA Approves Bispecific Lunsumio VELO™ by Roche
Roche has made an announcement that the US Food and Drug Administration (FDA) has provided approval for CD20xCD3 bispecific Lunsumio VELO™-mosunetuzumab as a subcutaneous...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...